Before your appointment, ensure you have a consultation with our skilled team to discuss your medical history, current medications, and weight loss goals
Some require steps that another pen does not require
An oral formulation of semaglutide (Rybelsus) is the first oral GLP-1RA approved for treating T2DM [ Table 2 ]
Zepbound Obstructive Sleep Apnea Zepbound is FDA-approved for treatment of moderate to severe obstructive sleep apnea
Pros Fully licensed and publicly traded, providing a layer of accountability Wide range of treatment categories beyond just weight loss Fast, convenient process for straightforward prescriptions Competitive pricing on many products, especially generics Discreet packaging and home delivery Available in all 50 states Cons Asynchronous consultations may feel impersonal, especially for complex treatments GLP-1 program relies on compounded medications, not brand-name drugs Limited provider continuity

For type 2 diabetes management , NICE guideline NG28 recommends GLP-1 receptor agonists as a treatment option when: Metformin and other oral medications have not achieved adequate glycaemic control The patient has a BMI of 35 kg/m or higher (or lower thresholds for people from South Asian and related minority ethnic backgrounds) Weight loss would benefit other obesity-related comorbidities Continuation of GLP-1 therapy for diabetes typically requires demonstration of beneficial response, defined as a reduction in HbA1c of at least 11 mmol/mol (1.0%) and weight loss of at least 3% of initial body weight at six months